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Abstract
Background: Prolactin (PRL) secretion is quantifiable as mean, peak and nadir PRL concentrations, degree of irregularity
(ApEn, approximate entropy) and spikiness (brief staccato-like fluctuations).
Hypothesis: Distinct PRL dynamics reflect relatively distinct (combinations of) subject variables, such as gender, age, and
BMI.
Location: Clinical Research Unit.
Subjects: Seventy-four healthy adults aged 22–77 yr (41 women and 33 men), with BMI 18.3–39.4 kg/m
2.
Measures: Immunofluorometric PRL assay of 10-min samples collected for 24 hours.
Results: Mean 24-h PRL concentration correlated jointly with gender (P,0.0001) and BMI (P=0.01), but not with age (overall
R
2=0.308, P,0.0001). Nadir PRL concentration correlated with gender only (P=0.017) and peak PRL with gender (P,0.001)
and negatively with age (P,0.003), overall R
2=0.325, P,0.0001. Forward-selection multivariate regression of PRL
deconvolution results demonstrated that basal (nonpulsatile) PRL secretion tended to be associated with BMI (R
2=0.058,
P=0.03), pulsatile secretion with gender (R
2=0.152, P=0.003), and total secretion with gender and BMI (R
2=0.204,
P,0.0001). Pulse mass was associated with gender (P=0.001) and with a negative tendency to age (P=0.038). In male
subjects older than 50 yr (but not in women) approximate entropy was increased (0.94260.301 vs. 1.25860.267, P=0.007)
compared with younger men, as well as spikiness (0.36360.122 vs. 046362.12, P=0.031). Cosinor analysis disclosed higher
mesor and amplitude in females than in men, but the acrophase was gender-independent. The acrophase was determined
by age and BMI (R
2=0.186, P=0.001).
Conclusion: In healthy adults, selective combinations of gender, age, and BMI specify distinct PRL dynamics, thus requiring
balanced representation of these variables in comparative PRL studies.
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Introduction
Prolactin (PRL) is a 23 kDa protein secreted by the pituitary
gland and has many actions of which the lactotrophic function is
best known. This hormone has various other effects on
reproduction, metabolism and tumorigenicity mainly described
in animals, but the precise role in the human is less well established
[1,2].
Prolactin secretion proceeds via combined pulsatile (burst-like)
and basal (time-invariant) modes of release. A complicating issue
in defining normative ranges even for measures of PRL secretion is
that they may depend upon one or more biological or clinical
factors, such as gender, age, BMI, sex-steroid concentrations, core
temperature, nutrition, stress, exercise, medications and renal
disease [1,3–9]. Prolactin secretion is primarily regulated by the
inhibitory action of hypothalamic dopamine, and by ultrashort
autofeedback, but the physiological role of various releasing
hormones is not established in man [2]. These factors would
putatively determine more complex PRL dynamics, which arise
physiologically from feedforward (stimulatory) and feedback
(inhibitory) signals interacting in an integrative fashion, as
demonstrated in detail for GH and LH in men [10]. Novel
integrative measures are approximate entropy (ApEn) and
spikiness, which reflect the complexity and stability of signaling
interactions in homeostatic systems [10].
Other pituitary hormone systems, including GH, TSH, ACTH
and LH exhibit age-, gender-, and BMI-related changes [11–13].
Although PRL levels are generally lower in men than in women,
the influence of aging and adiposity is less well investigated,
especially in men. The small size of most cohorts evaluated to date,
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inclusion of both genders collectively make the possibility of
statistical type I or type II errors high in earlier studies. As
importantly, because of correlations among age, BMI and gender,
multivariate regression is needed for definitive inferences.
Nonetheless, multivariate analysis also is unreliable in small
cohorts. To overcome these obstacles would require investigation
of a large number of healthy adults, both men and women, over
wide ranges of age and BMI. In this light, the present study
examines the dependencies of PRL release (mean, peak, nadir, 24-
h secretion, ApEn, spikiness) on individual and/or combined
clinical characteristics in 74 healthy individuals sampled frequently
(every 10 min) for a sufficiently representative duration (24 h) and
analyzed with a high-sensitivity PRL assay (immunofluorometric
platform).
Methods
Clinical protocol
The cohort of healthy individuals studied in this project,
originated from different studies, in which they served as controls,
including studies on PRL secretion in patients with prolactinoma,
obese subjects and patients with neurological disorders [3,14–18].
In these studies the women and men volunteered for and
completed the sampling study. Subjects originated from the same
community, and were evaluated in an identical sampling paradigm
and PRL assay (below). Informed written consent was obtained
from the subjects in all these published studies and the studies were
approved, including this retrospective analysis, by the ethics
committee of the Leiden University Medical Centre. All analyses
reported here used techniques not previously applied in any of the
published studies. Clinical characteristics of the volunteers (41
women and 33 men) are listed in Table 1. Postmenopausal
individuals studied here did not use estrogen therapy. Premeno-
pausal women were studied in the follicular phase of the menstrual
cycle.
Participants maintained conventional work and sleeping
patterns and reported no recent (within 10 days) transmeridian
travel, weight change (.2 kg in 6 weeks), shift work, psychosocial
stress, prescription medication use, substance abuse, neuropsychi-
atric illness, or acute or chronic systemic disease. A complete
medical history, physical examination, and screening biochemistry
tests were normal. Volunteers were admitted to the Study Unit the
evening before sampling for adaptation. Ambulation was permit-
ted to the lavatory only. Vigorous exercise, daytime sleep, snacks,
caffeinated beverages, and cigarette smoking were disallowed.
Meals were provided at 0900, 1230 and 1730 h, and room lights
were turned off between 2200 and 2400 h, depending upon
individual sleeping habits. Blood samples (2.0 mL) were with-
drawn at 10-min intervals for 24 h. Total blood loss was less than
360 mL. Volunteers were compensated for the time spent in the
study.
Assays
Plasma PRL concentrations were measured with a sensitive
time-resolved fluoroimmunoassay (Wallac Oy, Turku, Finland).
The limit of detection (defined as the value 2 SD above the mean
value of the zero standard) was 0.04 mg/L. The assay was
calibrated against the 3rd WHO standard 84/500. The intra-assay
coefficient of variation (CV) varied from 3.0–5.2% in the assay
range 0.1–250 mg/L, with corresponding interassay CV’s of 3.4–
6.2%. Serum estradiol concentrations were assayed by a sensitive
RIA (Spectria Estradiol Sensitive RIA, Orion Diagnostica, Espoo,
Finland).The detection limit of the assay is 5 pmol/L. The
intraassay CV was 21% at concentrations below 30 pmol, 4.5% at
85 nmol/L and 1.7% at 200 pmol/L. Testosterone was measured
by RIA (Siemens Healthcare Diagnostics, Deerfield, Il, USA). The
detection limit is 0.2 nmol/L. The intraassay CV at 1 nmol/L is
20% and at 14 nmol/L 12%. Free thyroxine was measured by
electrochemoluminescence immunoassay (Elecsys 2010, Roche
Diagnostics, Almere, The Netherlands). The detection limit is
0.6 pmol/L and the intraassay CV range amounts 5–8%. Serum
IGF-I concentration was measured with the Immulite 2500 system
(Diagnostic Products Corporation, Los Angeles, CA, USA). The
detection limit is 1.5 nmol/L. The intra-assay variation was 5.0
and 7.5% at levels of 8 and 75 nmol/L, respectively. Simple mean,
peak and nadir PRL concentrations Mean (24-h average), peak
(single daily maximum) and nadir (single daily minimum) PRL
concentrations were determined in each subject.
Deconvolution analysis
Prolactin concentration time series were analyzed via a recently
developed automated deconvolution method, empirically validat-
ed using hypothalamo-pituitary sampling and simulated pulsatile
time series [19–22]. The Matlab-based algorithm first detrends the
data and normalizes concentrations to the unit interval [0, 1].
Second, the program creates multiple successive potential pulse-
time sets, each containing one burst less via a smoothing process (a
nonlinear adaptation of the heat-diffusion equation). Third, a
maximum-likelihood expectation estimation method computes all
secretion and elimination parameters simultaneously conditional
on each of the multiple candidate pulse-time sets. Deconvolution
parameters comprise basal secretion (b0), two half-lives (a1,a2),
secretory-burst mass (g0, g1), random effects on burst mass (sA),
measurement error (se), and a three-parameter flexible Gamma-
secretory-burst waveform (b1, b2, b3). The unit-area normalized
shape of secretory bursts (plot of rate of secretion over time) was
permitted to differ in the day and night, thus constituting a dual-
waveform model of secretion. Two change point times were
estimated to demarcate onset of the day and onset of the nighttime
waveforms within each 24-h pulse train. For PRL, the fast half-life
was represented as 3.5 min constituting 37% of the decay
amplitude. The slow half-life was estimated as an unknown
variable between 20 and 50 min [23,24]. All candidate pulse-time
sets were deconvolved. Statistical model selection was then
performed to distinguish among the independently framed fits of
Table 1. Baseline subject characteristics.
Women (41) Men (33) P-value
Age (yr) 40 (22–77) 42 (21–77) 0.97
BMI (kg/m
2) 27.5 (18–39) 25.2 (21–36) 0.01
IGF-I (nmol/liter) 18 (10–35) 18.1 (9.9–32.1) 0.80
Estradiol (pmol/liter} 98 (5–297) 46 (24–90) ,0.0001
Testosterone (nmol/liter) 0.60 (0.10–1.2) 16 (12.5–23.1) ,0.0001
Free T4 (nmol/liter) 14.7 (12–18.6) 16 (12.5–23.1) 0.04
Mean PRL (mg/liter) 6.2 (2.0–18.4) 4.1 (2.1–9.7) ,0.0001
Peak PRL (mg/liter) 17.4 (7.1–38.2) 9.5 (4.9–25.1) ,0.0001
Nadir PRL (mg/liter) 2.8 (0.6–9.4) 1.9 (0.75–5.7) 0.005
PRL ApEn (unitless) 0.895 (0.270–1.807) 1.038 (0.400–1.913) 0.42
Spikiness (unitless) 0.326 (0.207–0.911) 0.361 (0.208–0.778) 0.24
Data are shown as median and range. Statistical evaluation was done with the
Kolmogorov-Smirnov test.
doi:10.1371/journal.pone.0031305.t001
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tion criterion. Observed interpulse intervals were described by a
two-parameter Weibull process (more general form of a Poisson
process, which uncouples the mean from the variance).The
parameters (and units) are frequency (number of bursts per total
sampling period, lambda of Weibull distribution), regularity of
interpulse intervals (unitless gamma of Weibull), slow half-life
(minutes), basal and pulsatile secretion rates (concentration units/
session), mass secreted per burst (concentration units), and
waveform shape (mode, or time delay to maximal secretion after
objectively estimated burst onset, in min). A typical example of
part of the graphic output of the deconvolution calculations is
shown in Fig. 1.
ApEn
Approximate Entropy (ApEn) is a sensitive and specific statistic
for discriminating insidious differences in serial dynamics. ApEn is
calculated for any time series as a single nonnegative number, with
zero denoting perfect orderliness, as for a sine wave, and larger
ApEn values corresponding to more apparently irregular dynamics
[25]. The ApEn metric evaluates the consistency of recurrent
subordinate (non-pulsatile) patterns in the data, and thus yields
information distinct from and complementary to deconvolution
(pulse) analyses [10,25]. In typical biological applications, ApEn
calculations are normalized against the SD of the data series by
defining a pattern-reproducibility threshold value of r=0.2 SD
validated for data lengths n$60 samples [26]. This choice of r
limits random effects of low measurement variability (typically
#0.065 SD), thus allowing discrimination between fine gradations
in the orderliness of the underlying process. Validation studies
have established the suitability of the m=1 as the pattern-
recurrence length for time series comprising 60,n,300 points, as
would be true for many endocrine profiles [26]. For this (m, r) pair,
there is quantifiably greater regularity (lower ApEn) of nocturnal
GH secretion in adult male than female rats castrated prepu-
bertally, as well as in normal men and women [27]. ApEn is
translation- and scale-independent mathematically, which means
that adding or multiplying each data value by a fixed number does
not alter ApEn [28]. This feature ensures valid comparisons
between different mean concentrations, overall variation, or
secretion rates due to age, gender, physiological state, and
pathology. For example, more irregular (higher ApEn, less orderly)
GH secretion occurs in patients with either hypersomatotropism
due to GH-secreting pituitary tumors or hyposomatotropism due
to hypopituitarism despite 1000-fold differences in GH production
[29,30].
Spikiness
Spikiness was defined as the ratio of the SD of the first-
differenced (incremental) time series to the SD of the original series
[31]. Spikiness quantifies the extent of sharp, brief, staccato-like
unpatterned fluctuations.
Cosinor analysis
The diurnal variation of PRL was analyzed by a non-linear
cosine approximation. Measures are the mesor (average level
around which the 24-hour oscillation occurs), amplitude (half of
the difference between the highest and lowest values) and
acrophase (time of the maximum).
Statistical analysis
Stepwise forward-selection multivariate linear regression anal-
ysis of untransformed PRL measures was used to examine
correlations between preselected PRL parameters (individual
dependent variables) and one or more of age, BMI, gender and
serum hormone concentrations (independent variables). Statistical
comparisons by gender were carried out via the nonparametric
Kolmogorov-Smirnov test. Significant contrasts were confirmed
by unpaired two-tailed Student’s t-test of log-transformed PRL-
deconvolution measures. In addition, ANOVA was used for
comparisons of more than 2 groups. Data are given as median and
absolute range, and as mean and standard deviation or standard
error. Analyses used Systat, version 11 (SPSS Inc., Chicago, IL,
USA). P,0.05 was considered significant.
Results
Table 1 shows the median (absolute range) subject character-
istics for the 33 men and 41 women. Their ages were similar, but
the BMI was higher in women than men. Estradiol and testo-
sterone concentrations were as expected for the genders, but free
thyroxine was higher in men than women and within normal
limits, while IGF-I concentrations did not differ between genders.
Mean 24-h, peak and nadir PRL concentrations were all larger in
Figure 1. Part of the graphic output of the deconvolution
analysis in a male control subject, the upper panel shows the
original serum PRL concentrations (mg/L) and the fitted
concentration curve (interrupted line). Asterisks denote pulse
onsets, and the rhomboids the time of waveform switch. Time 0 min is
0900 hr. The second panel shows the secretion rate in mg/L.min. The
third panel represents the secretion rate within bursts (normalized
secretion over time) for the daytime (interrupted line) and nighttime
(continuous line), stressing the difference in time at which the maximal
secretion rate is reached. The lowest plot shows the statistical
distribution of the interpulse delays.
doi:10.1371/journal.pone.0031305.g001
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elevations) were similar in men and women (Table 1).
The serum PRL profiles across the 24 hour cycle are displayed
in Fig. 2, showing the marked gender differences, especially during
the phase with lights off.
Stepwise forward-selection multivariate regression analysis was
employed to assess the association of individual PRL measures
with gender, age and BMI. Mean 24-h PRL concentration was
associated with gender (female.male, P,0.0001) and BMI
(P=0.01), but not with age (R
2=0.308, ANOVA P,0.0001)
(see Fig. 3). Nadir PRL concentration correlated with gender only
(R
2=0.077, P=0.017). However, peak PRL concentration
correlated with gender (P,0.0001) and negatively with age
(P,0.0001), overall R
2=0.325, P,0.0001 (see Fig. 4). PRL
ApEn, a measure of secretory regularity, and spikiness, a metric of
brief, staccato-like increases in secretion, were gender-, age- and
BMI-invariant.
Based on deconvolution analysis and on unpaired statistical
comparisons, gender determined pulsatile PRL secretion
(P,0.0001), total secretion (P,0.0001), but not basal secretion.
Pulsatile secretion was amplified by 1.5 fold due to increased burst
mass in women, with unchanged pulse frequency (Table 2).
Forward-selection multivariate regression of PRL deconvolution
results demonstrated that basal (nonpulsatile) secretion tended to
be associated with BMI (R
2=0.058, P=0.03), pulsatile secretion
with gender (R
2=0.152, P=0.003), and total secretion with
gender and BMI (R
2=0.204, P,0.0001, Fig. 5). Pulse mass was
associated with gender (P=0.001) and with a negative tendency to
age (P=0.038) (Fig. 6).
We also compared results in premenopausal women with
postmenopausal women. In postmenopausal women the following
parameters were smaller than in women with a regular menstrual
cycle:mean 24 hPRL,peakPRL,fastingPRL, nadirPRL,pulsatile
secretion, mean pulse mass and total secretion (see Table 3).
However, these parameters were not different in postmenopausal
women and men (P-values lying between 0.27 and 0.75) (Table 3).
In male subjects older than 50 yr, ApEn (0.94260.301 vs.
Figure 2. Twenty-four hour serum PRL concentration profiles in
41 healthy women and 33 healthy men. Blood samples were
drawn every 10 min. Data are shown as mean, and the bars represent
the SEM. The period with lights off (shown as the black horizontal bar)
was between 2300 and 0700 h.
doi:10.1371/journal.pone.0031305.g002
Figure 3. Multiple linear regression between age, gender and
mean serum PRL concentration. Data were obtained in 74 healthy
subjects, who underwent 24-h blood sampling at 10-min intervals. Male
subjects are shown as triangles, female subjects as circles. Data points
above the regression plane are open, below they are closed.
doi:10.1371/journal.pone.0031305.g003
Figure 4. Multiple linear regression between age, gender and
maximal PRL concentration in the 24-h serum profile. Data were
obtained in 74 healthy subjects, who underwent 24-h blood sampling
at 10-min intervals. Male subjects are shown as triangles, female
subjects as circles. Data points above the regression plane are open,
below they are closed.
doi:10.1371/journal.pone.0031305.g004
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0.46360.212, P=0.031) were increased compared with values in
younger men. Other parameters were statistically not different.
In the linear regression analyses of the PRL secretion
parameters with age, BMI, gender and serum estradiol concen-
tration, the last was an independent predictor of total PRL
secretion (P=0.002), basal secretion (P=0.01), mean 24-h
concentration (P=0.002), minimal concentration (P=0.002), but
not of pulsatile secretion (P=0.51), and maximal concentration
(P=0.32). Since we had testosterone values only in men, and with
a few exceptions not in women, the regression analysis of the
influence of testosterone was restricted to men. None of the
parameters was related to the serum testosterone concentration.
Pulsatile PRL secretion was dependent on the diurnal cycle.
During day time PRL secretion in men amounted 51.0 (14–239)
mg/liter.24 h and in women 79.0 (26–358) mg/liter.24 h, P=0.22.
During the period with lights off these values were 61.0 (16–111)
mg/liter.24 h in men and 111.0 (26–421) mg/liter.24 h in women,
P=0.001 (Fig. 7).
All subjects had a significant diurnal PRL rhythm. The detailed
results are displayed in Table 4. The mesor and amplitude were
larger in women than men, but the time at which the maximal
value was obtained did not differ between genders. The acrophase
correlated negatively with BMI and age (R
2=0.186, P=0.003),
see Fig. 8.
Figure 5. Multiple linear regression between age, gender and
total logarithmically transformed PRL secretion, calculated by
deconvolution analysis. Data were obtained in 74 healthy subjects,
who underwent 24-h blood sampling at 10-min intervals. Male subjects
are shown as triangles, female subjects as circles. Data points above the
regression plane are open, below they are closed.
doi:10.1371/journal.pone.0031305.g005
Table 2. Prolactin deconvolution parameters in men and women.
All (n=74) Women (n=44) Men (n=33) K-S test Student’s t-test
Number of pulses (24 h
21) 19 (12–29) 19 (12–28) 19 (13–29) 0.80 0.82
Slow half-life (min) 34.6 (20–45) 34 (20–45) 34.8 (20–45) 0.52 0.85
Day mode (min) 9.8 (3–23.9) 9.2(3–21) 9.8 (3–23.9) 0.72 0.70
Night mode (min) 11.5 (3–30) 13.6 (3.1–30) 11.2 (3–17.4) 0.12 0.29
Basal secretion (mg/liter.24 h) 104 (91–530) 119 (9–530) 84(22–260) 0.15 0.41
Pulsatile secretion (mg/liter.24 h) 114(30–675) 138(60–675) 91(30–260) 0.002 ,0.0001
Total secretion (mg/liter.24 h) 235(83–780) 284(83–780) 187(90–380) 0.009 ,0.0001
Mass per burst (mg/liter) 6.1 (1.7–29.5) 7.4 (2.8–29.5) 4.6 (1.7–13.6) 0.01 ,0.0001
Lambda(frequency/24 h,unitless) 17.8 (11.8–26.1) 17.8 (11.8–26.1) 17.8 (11.9–25.5) 0.96 0.92
Gamma (regularity, unitless)) 1.92 (1.28–3.71) 1.95 (1.28–3.71) 1.88 (1.41–2.80) 0.51 0.30
Data are shown as median and range. Statistical comparisons were done with the Kolmogorov-Smirnov test and the unpaired Student’s t-test after logarithmic
transformation of the data.
doi:10.1371/journal.pone.0031305.t002
Figure 6. Multiple linear regression between age, gender and
mean PRL pulse mass, calculated by deconvolution analysis.
Data were obtained in 74 healthy subjects, who underwent 24-h blood
sampling at 10-min intervals. Male subjects are shown as triangles,
female subjects as circles. Data points above the regression plane are
open, below they are closed.
doi:10.1371/journal.pone.0031305.g006
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This study evaluated simple and complex measures of prolactin
secretion in relation to gender (women vs men), age and BMI.
Simple measures of prolactin secretion, e.g. nadir, peak and mean
levels, as used in clinical settings, showed a strong relation to
gender, age (decreased peak value only) and BMI (increased mean
and nadir). Deconvolution analysis showed that pulsatile, but not
basal (non-pulsatile), secretion was larger in women than men and
caused by amplified mean burst mass with unchanged pulse
frequency. Basal secretion was positively dependent on BMI and
serum estradiol concentration.
Recent publications on 24-h secretion profiles of pituitary
hormones in the human, with a 10-min sampling scheme,
measured with robust and sensitive assays, and analyzed with
operator-independent tools have demonstrated different impacts of
gender, age and BMI in multivariate regression analysis. For
instance, GH secretion in 100 adult subjects was determined
independently by age, BMI and gender, thus decreasing by
advancing age and increasing BMI, and with a higher secretion
rate in women than men [11]. In contrast, ACTH secretion is
larger in men than women, and positively correlated with BMI
[13]. On the other hand, TSH secretion is gender invariant and
only age-dependent in women [12].
The present study shows that PRL secretion is especially
determined by gender and BMI. When analyzed separately post-
menopausal women exhibited a 40% decrease in PRL secretion
compared with premenopausal women in the follicular phase of
their menstrual cycle. Healthy men did not show a decrease after
age fifty, but rather exhibited a slight 18% increase, suggesting that
age per se may not be the cause of the decrease in women.
Therefore, studies on PRL physiology and pathophysiology
Table 3. Prolactin secretion characteristics in premenopausal and postmenopausal women, and men.
Men Pre MP women Post MP women ANOVA P-value
Men vs Post
MP women
Pre MP vs
Post MP
BMI 25.263.50 28.566.39 21.863.1 0.12
Pulse frequency (nr/24 h) 19.564.0 18.964.5 32.469.1 0.13
Slow half-life (min) 33.267.8 34.368.3 8.165.6 0.80
Mode day (min) 10.965.2 10.465.1 10.465.4 0.29
Mode night (min) 11.264.8 12.866.4 128682 0.92
Basal secretion (mg/L.24 h) 106657 1636138 113634 0.73
Pulsatile secretion (mg/L.24 h) 101646 2036147 241682 ,0.001 0.30 ,0.001
Total secretion (mg/L.24 h) 207682 3666188 5.1761.77 ,0.001 0.31 0.02
Mean pulse mass (mg/L) 5.362.53 10.661.17 19.563.5 ,0.001 0.74 0.001
Lambda ( pulse frequency) 18.163.6 17.663.9 2.13860.427 0.25
Gamma (regularity, unitless) 1.94360.352 2.01760.433 1.02360.337 0.06
ApEn (unitless) 1.03260.314 0.93060.349 0.38160.127 0.32
Spikiness (unitless) 0.39160.130 0.36360.143 5.1062.09 0.56
Mean 24 h PRL (mg/L) 4.3561.46 7.7263.16 2.5261.09 ,0.001 0.27 0.001
Minimum PRL(mg/L) 2.1361.03 3.4962.16 11.364.56 0.005 0.46 0.08
Maximum PRL (mg/L) 10.764.04 20.367.07 3.8861.42 ,0.001 0.75 ,0.001
Fasting PRL (mg/L) 4.1861.51 7.0165.17 3.8861.42 0.001 0.48 0.002
Data are shown as mean and standard deviation.Comparisons between groups were made with ANOVA after logarithmic transformation of the data. Contrasts between
groups were made only if the overall ANOVA was significant. MP: menopausal.
doi:10.1371/journal.pone.0031305.t003
Figure 7. Box plots of the pulsatile PRL secretion during day
time and during the period with lights off (2300 -0700 h).
Differences between men and women were calculated with the
Kolmogorov-Smirnov test.
doi:10.1371/journal.pone.0031305.g007
Table 4. Cosinor analysis of the 24-h serum prolactin profiles
in healthy subjects.
men women P-value
Mesor (mg/L) 3.9060.25 5.9160.47 ,0.001
Amplitude(mg/L) 1.1260.10 1.9260.17 ,0.001
Acrophase (clock hours a.m. 3.9760.28 3.7260.25 0.52
Data are shown as mean 6 SEM. Statistical comparisons were made with the
Student’s t-test for unpaired data.
doi:10.1371/journal.pone.0031305.t004
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comparisons.
One obvious cause for the decrease in PRL in women is the lack
of estrogens in the menopausal phase, as suggested by the
regression analysis in women. However the role of estrogens in
regulating PRL secretion is certainly not straightforward. During
the menstrual cycle no influence of different estradiol concentra-
tions on PRL is demonstrable, but in this study only part of the
24 h cycle was analyzed [32]. Furthermore, the PRL increase after
TRH injection is independent of the stage of the menstrual cycle
[33]. However the value of such studies is limited because of the
non-physiological TRH dose, which achieved PRL levels higher
than those in spontaneous PRL secretory patterns. On the other
hand, high dose orally administered estradiol in postmenopausal
women, leading to greatly increased estradiol levels increases PRL.
This does not occur after transdermal administration [34]. Other
studies have even shown a decrease in PRL after transdermal
estrogen administration in postmenopausal women [35], or no
change [36]. However, it is conceivable that long-term effects of
estrogens regulate the prolactin cell mass, thus explaining
hypothetically the remarkable decrease in serum PRL concentra-
tion after menopause and possibly also the moderate increase in
elderly men by enhanced bioavailable estradiol [37].
Interestingly, estradiol correlated with basal PRL secretion and
the minimal 24-h concentration, and secondary to this the mean
24-h concentration and total secretion, but not with pulsatile
secretion and the maximal value. This observation suggests a
diminished restraint on secretion, but the mechanisms involved are
currently not known. In addition, this observation also underlines
a marked difference with GH secretion, where estrogens increase
specifically pulsatile secretion [38,39].The present result, however,
should be confirmed by estradiol measurements with the more
precise high performance liquid chromatography-tandem mass
spectrometry [40] and free estradiol. Collectively, the impact of
estrogens on PRL secretion is still not completely clear, partly
because of nonphysiological experiments and partly because of
correlation studies that do not prove a causal role. Potentially,
blocking of the estrogen receptor by specific drugs may provide
more insight into the physiological role of estrogens on PRL
secretion.
Leptin is one of the various factors modulating PRL secretion
and the administration restores lactation in the leptin-deficient ob/
ob mice [41]. Infusion of leptin raises serum PRL concentration in
fasted rats to levels present in normal fed animals [42].
Furthermore, a direct effect on PRL secretion by leptin on the
pituitary in vitro has also been demonstrated [43]. Therefore, it is
possible that age- and gender-dependent differences in serum
leptin concentrations, i.e higher levels in women than men, and a
20% decrease after menopause, modulate PRL secretion as we
describe in this study [44]. Unfortunately, leptin levels were
measured only in a limited number of subjects, so that we could
not investigate the relationship between this hormone and PRL
secretion parameters.
Differences in PRL secretion between genders have rarely been
investigated in relation to the diurnal cycle and not yet with
deconvolution techniques. In this study the gender difference was
only present during the sleep period but not during day time. This
finding suggests that the dopamine restraint and putative
stimulatory factors exhibit circadian properties, but also reveals
the impact of gender.
Increased age is characterized by advance (earlier in day)
shifting of acrophases of rhythms and diminished amplitude,
possibly related to sleep fragmentation and earlier sleep onset and
awakening [45]. In this study, age was weakly negatively
correlated with PRL pulse mass and the maximal value attained
during the 24-h rhythm. Studies which compared nocturnal PRL
secretion in elderly and young subjects established decreased pulse
amplitude in older age [46,47]. On the other hand, PRL secretion
during the daytime was age-invariant [46].The latter observation
suggests that the decrease in nocturnal PRL secretion is not the
result of decreased lactotrope cell mass. In another study in men
aged 30–96 yr, non-fasting early afternoon serum PRL concen-
tration increased slightly with advancing age, which was
attributable to subjects older than 75 yr, whose data are not
included in other investigations with a lesser age span [48]. Indeed,
another analysis comparing basal and TRH-stimulated PRL
concentrations in two age groups (23–45 vs. 56–75 yr) found
comparable basal levels, but a negative correlation between age
and stimulated PRL concentration [49]. Collectively, these
observations are consistent with altered (increased) dopaminergic
tonus in the elderly during the sleep period, and which can be
restored by metoclopramide administration and diminished
responsiveness of the prolactin-secreting cell to TRH [5]. Body
composition is an important modulator of hormone secretion, as
found for instance for insulin, leptin, TSH, ACTH and cortisol
secretion. In this study, total PRL secretion was correlated with
BMI in both genders. This result corroborates the notion of
enhanced PRL secretion in obesity in most studies [3,50], but not
all [51]. Weight reduction by very low calorie diet or bariatric
surgery diminished PRL secretion [52–54]. However, in a study by
Ernst and colleagues no change in basal PRL levels was observed
after massive weight loss (average 50 kg) in their patients [50].
Whether this finding is the result of differences in experimental
design, i.e, frequent blood sampling with deconvolution versus a
single fasting morning specimen, is not known.
Approximate Entropy of PRL was increased in elderly men
compared with subjects younger than 50 yr, but not in women. A
common denominator of irregularity is attenuation of negative
Figure 8. Multiple linear regression between age, BMI and the
acrophase of the PRL rhythm. Data points above the regression
plane are open, below the plane they are closed. There were no gender
differences in acrophase.
doi:10.1371/journal.pone.0031305.g008
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that impair feedback elevate ApEn (process randomness). Well-
established conditions of high ApEn include primary failure of a
target gland like the thyroid, testis, and ovary, autonomous
endocrine tumors, and PCOS [55–61]. Additionally, excessive
feedforward enforces irregular patterns. Parathyroid hormone
secretion is more disorderly in hyperparathyroidism [62], as is
aldosterone secretion in primary and secondary hyperaldosteron-
ism [63]. In keeping with these observations, irregularity can be
induced experimentally by muting negative feedback by testoster-
one, cortisol, and IGF-I, which normally maintain regularity of
their upstream hormones (LH, ACTH, GH), as well as by
augmenting feedforward by GnRH or GHRH on downstream
hormones (LH and GH) [64]. In old age hormone secretory
regularity is generally diminished, as described for GH, cortisol,
and LH, but not ACTH and TSH [11–13], and here in elderly
men for PRL, but not in women. Nonetheless, one previous study
in 10 young and 10 old men found a non-significant 20% rise in
PRL ApEn in elderly men [65]. Clearly, more elderly healthy
subjects, with ages extending into the nineties are required to
confirm ApEn changes of PRL secretion with age.
Spikiness is a measure of sharp staccato-like excursions in serial
measurements, putatively reflecting acute stimuli from outside
normative feedback loops [31]. In elderly men, spikiness was
increased compared with younger males. In another large study by
us, GH spikiness was determined jointly by gender (higher in
women) and BMI (positively), accounting for 29% of inter
individual variability. Spikiness also marks other endocrine
physiology and pathophysiology, such as greater survival when
applied to serial glucose data in patients with protracted critical
illness, older age in women when applied to ACTH time series,
sharper TSH excursions in hypothyroidism and thyrotropinoma
compared with normal, and unstable premenstrual mood-rating
dynamics in dysphoria and response to therapy in the latter group
[13,66–68]. Recognition of increased spikiness in older adults is
important in planning investigations in this age group because
greater spikiness would decrease statistical power by accentuating
single-sample variability in aging individuals.
As expected, and concordant with the literature, the mesor and
amplitude were larger in women than in men [69]. No gender
difference was found for the acrophase of the PRL rhythm. A
novel finding in this study was the dependence of the acrophase on
BMI and age, both causing an advance shift, thus leading to an
earlier maximum. This result is comparable with the advanced
shift of cortisol in elderly subjects reported in other studies [70–
72]. The mechanism(s) behind these shifts are not known,
although changes in the sleep quality have been advocated [70].
However, no detailed studies on the effect of adiposity on hormone
acrophases are available.
This study has several limitations. First, the retrospective design
could have introduced a selection bias, because the volunteers
participated in several independent studies as mentioned in the
Introduction. However all subjects were recruited by advertise-
ments from the local area. In addition all subjects underwent a
structured medical history assessment, physical examination and
routine clinical chemistry. The sampling protocol and chemical
methods were identical in these studies and all studies were
uneventful. Although we cannot completely rule out stress or
anxiety in the volunteers, we did not detect this in the individual
serum hormone patterns. Second, as mentioned above we did not
use the more sensitive and specific high performance liquid
chromatography-tandem mass spectrometry, but a reasonably
sensitive, but necessarily less accurate estradiol RIA. Third, we
have not included healthy volunteers aged over eighty years.
Future inclusion of this cohort into the analysis may strengthen
conclusions.
In summary, in healthy adults, selective combinations of gender,
age, and BMI specify distinct PRL dynamics, thus requiring
balanced representation of these variables in comparative PRL
studies.
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